Mouse Tumor Biology Database (MTB)
MTB Home   Help
Search for Help
 
in these sections
Search Forms
Tumor
Strain
Genetics
Pathology Images
Reference
Advanced
Search MTB Using Human Genes
Gene Expression Data Sets

Additional Resources
new PDX Like Me
PDX Finder
PDX Model Search
Faceted Tumor Search
Dynamic Tumor Frequency Grid
Other Cancer Websites
Immunohistochemistry
Lymphoma Pathology

Mouse Genome Informatics
The Jackson Laboratory
Citing These Resources
Warranty Disclaimer
& Copyright Notice

Send Questions and
Comments to User Support.

Last Database Update
2019-11-10
MTB 3.0
 
HelpHelp and Documentation Strain Search Results  
Search Summary
Sort By: Name
Display Limit: No Limit
13 matching items displayed.
Strain Name Strain Type Strain Notes
STOCK Cdkn2atm1Nesh Tg(Tyr-HRAS)60Lc targeted mutation (knockout) &
transgenic
Mice were homozygous for Cdkn2atm1Nesh and carried the transgene. This STOCK genetic background was stated to be >75% FVB/N and included contributions from C57BL/6J, CBA/J, SJL/J, 129S6/SvEvTac, and 129/Sv (substrain unspecified).
STOCK Cdkn2atm1Nesh/+ Tg(Tyr-HRAS)60Lc targeted mutation (knockout) &
transgenic
Mice were heterozygous for Cdkn2atm1Nesh and carried the transgene. This STOCK genetic background was stated to be >75% FVB/N and included contributions from C57BL/6J, CBA/J, SJL/J, 129S6/SvEvTac, and 129/Sv (substrain unspecified).
STOCK Cdkn2atm2.1Rdp Tg(Tyr-HRAS)60Lc targeted mutation (knockout) &
transgenic
Mice were homozygous for Cdkn2atm2.1Rdp and carried the transgene. This STOCK genetic background was stated to be >75% FVB/N and included contributions from C57BL/6J, CBA/J, SJL/J, 129S6/SvEvTac, and 129/Sv (substrain unspecified).
STOCK Cdkn2atm2.1Rdp/+ Tg(Tyr-HRAS)60Lc targeted mutation (knockout) &
transgenic
Mice were heterozygous for Cdkn2atm2.1Rdp and carried the transgene. This STOCK genetic background was said to be >75% FVB/N and included contributions from C57BL/6J, CBA/J, SJL/J, 129S6/SvEvTac, and 129/Sv (substrain unspecified).
STOCK Tg(Tyr-HRAS)60Lc transgenic This STOCK genetic background was a mixture of C57BL/6J, CBA/J, "129/Sv" (substrain unspecified), and SJL/J.
STOCK Tg(Tyr-HRAS)60Lc transgenic This STOCK genetic background was stated to be ~75% FVB (N2), additional strain backgrounds present included 129S6/SvEvTac, C57BL/6J, and CBA/J.
STOCK Tg(Tyr-HRAS)60Lc transgenic This STOCK genetic background was stated to be >75% FVB/N and included contributions from C57BL/6J, CBA/J, SJL/J, 129S6/SvEvTac, and 129/Sv (substrain unspecified).
STOCK Tg(Tyr-HRAS)60Lc Cdkn2atm1Rdp targeted mutation (knockout) &
transgenic
Mice were homozygous for the Cdkn2a mutant allele and carried the transgene. This STOCK genetic background was a mixture of C57BL/6J, CBA/J, "129/Sv" (substrain unspecified), and SJL/J.
STOCK Tg(Tyr-HRAS)60Lc Cdkn2atm1Rdp/+ targeted mutation (knockout) &
transgenic
Mice were heterozygous for the Cdkn2a allele and carried the transgene. This STOCK genetic background was a mixture of C57BL/6J, CBA/J, "129/Sv" (substrain unspecified), and SJL/J.
[not specified]-Cdkn2atm1Rdp Tg(Tyr-HRAS)60Lc targeted mutation (knockout) &
transgenic
Compound mutant mice. The genetic background of these mice was not specified but may have included C57BL/6J, CBA/J, "129/Sv" (substrain not specified), and/or SJL.
[not specified]-Tg(Tyr-HRAS)60Lc Cdkn2atm1Rdp targeted mutation (knockout) &
transgenic
Mice homozygous for a targeted mutation of Cdkn2a (INK4a-ARF) and transgenic for an activated human HRAS (G12V) oncogene under control of the melanocyte-specific mouse tyrosinase promoter. Genetic background not specified.
[not specified]-Tg(Tyr-HRAS)60Lc Trp53tm1Tyj targeted mutation (knockout) &
transgenic
Mice homozygous for a targeted mutation of Trp53 and transgenic for an activated human HRAS (G12V) oncogene under control of the melanocyte-specific mouse tyrosinase promoter. Genetic background was not specified.
[not specified]-Tg(Tyr-HRAS)60Lc Trp53tm1Tyj/+ targeted mutation (knockout) &
transgenic
Mice heterozygous for a targeted mutation of Trp53 and transgenic for an activated human HRAS (G12V) oncogene under control of the melanocyte-specific mouse tyrosinase promoter. Genetic background was not specified.